Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,240 | 2 | 49.5% |
| Consulting Fee | $2,548 | 3 | 38.9% |
| Food and Beverage | $425.81 | 6 | 6.5% |
| Education | $280.99 | 3 | 4.3% |
| Travel and Lodging | $49.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $3,593 | 7 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $2,450 | 2 | $0 (2024) |
| Veloxis Pharmaceuticals, Inc. | $276.72 | 4 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $125.00 | 1 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $99.99 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,575 | 3 | CALLIDITAS THERAPEUTICS US INC. ($2,450) |
| 2023 | $44.38 | 1 | Horizon Therapeutics plc ($44.38) |
| 2022 | $1,912 | 5 | Horizon Therapeutics plc ($1,856) |
| 2021 | $1,693 | 2 | Horizon Therapeutics plc ($1,693) |
| 2019 | $230.00 | 3 | Veloxis Pharmaceuticals, Inc. ($130.01) |
| 2018 | $90.72 | 1 | Veloxis Pharmaceuticals, Inc. ($90.72) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 06/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Nephrology | ||||||
| 06/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $49.99 | General |
| Category: Nephrology | ||||||
| 06/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $44.38 | General |
| Category: KRYSTEXXA | ||||||
| 06/06/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $1,620.00 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $138.09 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | In-kind items and services | $74.80 | General |
| Category: KRYSTEXXA | ||||||
| 05/19/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Education | In-kind items and services | $55.99 | General |
| Category: Immunosuppresant | ||||||
| 10/20/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $1,620.00 | General |
| Category: KRYSTEXXA | ||||||
| 10/20/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | In-kind items and services | $73.00 | General |
| Category: KRYSTEXXA | ||||||
| 12/06/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/01/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Education | In-kind items and services | $125.01 | General |
| Category: Immunosuppressant | ||||||
| 01/15/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Immunosuppressant | ||||||
| 06/04/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $90.72 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 379 | 544 | $206,994 | $30,701 |
| 2022 | 14 | 444 | 671 | $255,265 | $37,958 |
| 2021 | 17 | 482 | 856 | $254,368 | $39,277 |
| 2020 | 21 | 625 | 1,083 | $262,171 | $42,705 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 146 | 179 | $56,313 | $11,874 | 21.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 57 | $23,074 | $5,072 | 22.0% |
| 50200 | Needle biopsy of kidney | Facility | 2023 | 34 | 36 | $63,749 | $3,345 | 5.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 45 | $12,465 | $2,661 | 21.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $12,785 | $2,335 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $5,977 | $1,631 | 27.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 19 | $10,469 | $1,625 | 15.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 16 | $9,440 | $856.48 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 63 | $2,205 | $529.20 | 24.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 34 | 36 | $3,790 | $494.74 | 13.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 20 | 21 | $4,767 | $189.00 | 4.0% |
| 85048 | Automated white blood cell count | Office | 2023 | 11 | 35 | $1,960 | $87.15 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 137 | 162 | $47,628 | $10,379 | 21.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 115 | $44,965 | $8,841 | 19.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 88 | $24,376 | $4,404 | 18.1% |
| 50200 | Needle biopsy of kidney | Facility | 2022 | 40 | 43 | $76,110 | $4,077 | 5.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 17 | $11,611 | $2,537 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 24 | $7,056 | $1,986 | 28.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 24 | 24 | $13,224 | $1,881 | 14.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 12 | 21 | $12,390 | $1,159 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 20 | $4,080 | $911.52 | 22.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $4,158 | $815.42 | 19.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 38 | 41 | $1,506 | $506.31 | 33.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 57 | $1,881 | $169.23 | 9.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 18 | 18 | $4,086 | $165.50 | 4.1% |
About Dr. Sandesh Parajuli, MBBS
Dr. Sandesh Parajuli, MBBS is a Nephrology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1184861718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandesh Parajuli, MBBS has received a total of $6,545 in payments from pharmaceutical and medical device companies, with $2,575 received in 2024. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Honoraria" ($3,240).
As a Medicare-enrolled provider, Parajuli has provided services to 1,930 Medicare beneficiaries, totaling 3,154 services with total Medicare billing of $150,641. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Madison, WI
- Active Since 01/20/2009
- Last Updated 01/20/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1184861718
Products in Payments
- KRYSTEXXA (Biological) $3,593
- TARPEYO (Drug) $2,450
- Envarsus (Drug) $186.00
- Auryxia (Drug) $125.00
- ACTHAR (Biological) $99.99
- Envarsus XR (SP) (Drug) $90.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Madison
Didier Mandelbrot, M.d, M.D
Nephrology — Payments: $9,379
Dr. Sayee Sundar Alagusundaramoorthy, M.b.b.s.,, M.B.B.S.,
Nephrology — Payments: $6,245
Andrey Vavrenyuk, Md, MD
Nephrology — Payments: $1,161
Nolan Interial, Do, DO
Nephrology — Payments: $391.54
Roy Jhagroo, M.d, M.D
Nephrology — Payments: $375.62
Prabesh Aryal, Mbbs, MBBS
Nephrology — Payments: $103.09